15578 Federal Register / Vol. 89, No. 43 / Monday, March 4, 2024 / Notices 

comments may be made available to the 

Committee for their consideration and 

public distribution. Written comments 

should be submitted by email to 

CLIAC@cdc.gov or to the contact person 

above. All written comments will be 

included in the meeting minutes posted 

on the CLIAC website. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–04432 Filed 3–1–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Award of a Sole Source 

Cooperative Agreement To Fund 

Uganda National Health Laboratories 

and Diagnostic Services (NHLDS) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS), announces the 

award of approximately $10,000,000, for 

Year 1 funding to NHLDS. The award 

will strengthen laboratory systems in 

Uganda by contributing to the 

attainment of HIV epidemic control and 

establishing sustainable and integrated 

systems for quality assured disease 

diagnostics, monitoring, and 

surveillance. Funding amounts for years 

2–5 will be set at continuation. 

DATES: The period for this award will be 

September 30, 2024, through September 

29, 2029. 

FOR FURTHER INFORMATION CONTACT: 

Christina Mwangi, Center for Global 

Health, Centers for Disease Control and 

Prevention, US Embassy Kampala, US 

Centers for Disease Control and 

Prevention, 1577 Ggaba Road, 

Telephone: 256772139023, Email: 

mwn0@cdc.gov. 

SUPPLEMENTARY INFORMATION: The sole 

source award will strengthen Uganda’s 

access to quality laboratory services 

during the scale up of HIV prevention, 

care, and treatment by supporting 

implementation of the Uganda National 

Health Laboratory Services (UNHLS) 

Policy II (2016) and its Strategic Plan 

(2020–2025). 

NHLDS is in a unique position to 

conduct this work, as it is the primary 

stakeholder of laboratory-related policy 

development, strategic planning, and 

resources mobilization for the Ministry 

of Health (MOH). Additionally, NHLDS 

directly houses and manages the Central 

Public Health Reference Laboratory 

(CPHL) which is the national reference 

laboratory for HIV early infant diagnosis 

and viral load, national microbiology 

reference laboratory, national 

Tuberculosis (TB) reference laboratory, 

the national laboratory biorepository 

and national equipment calibration 

center. Furthermore, the NHLDS is the 

primary coordinator of the integrated 

national laboratory specimen 

transportation network that handles 

both HIV, TB and outbreak specimen 

referral across the country. 

Summary of the Award 

Recipient: Uganda National Health 

Laboratories and Diagnostic Services 

(NHLDS). 

Purpose of the Award: The purpose of 

this award is to strengthen laboratory 

systems in Uganda by contributing to 

the attainment of HIV epidemic control 

and establishing sustainable and 

integrated systems for quality assured 

disease diagnostics, monitoring, and 

surveillance. 

Amount of Award: For NHLDS, the 

approximate year 1 funding amount will 

be $10,000,000 in Federal Fiscal Year 

(FYY) 2024 funds, subject to the 

availability of funds. Funding amounts 

for years 2–5 will be set at continuation. Authority: This program is authorized 

under Public Law 108–25 (the United 

States Leadership Against HIV AIDS, 

Tuberculosis and Malaria Act of 2003) 

[22 U.S.C. 7601, et seq.] and Public Law 

110–293 (the Tom Lantos and Henry J. 

Hyde United States Global Leadership 

Against HIV/AIDS, Tuberculosis, and 

Malaria Reauthorization Act of 2008), 

and Public Law 113–56 (PEPFAR 

Stewardship and Oversight Act of 2013). Period of Performance: The period for 

this award will be September 30, 2024, 

through September 29, 2029. 

Dated: February 26, 2024. 

Jamie Legier, 

Acting Director, Office of Grants Services, 

Centers for Disease Control and Prevention. 

[FR Doc. 2024–04399 Filed 3–1–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Solicitation of Nominations for 

Appointment to the Communications 

and Public Engagement Workgroup 

(CPEW) of the Advisory Committee to 

the Director (ACD), CDC 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), within 

the Department of Health and Human 

Services (HHS), is seeking nominations 

for membership to the Communications 

and Public Engagement Workgroup 

(CPEW) of the Advisory Committee to 

the Director, CDC. The CPEW 

workgroup consists of approximately 15 

members who are experts in the fields 

associated with communications, 

including public relations, health 

communication, risk communication, 

communication research, and 

marketing; community and partner 

engagement; public health science and 

practice, including implementation; and 

behavioral science/behavior change 

campaigns. 

DATES: Nominations for membership on 

the CPEW workgroup must be received 

no later than March 28, 2024. Late 

nominations will not be considered for 

membership. 

ADDRESSES: All nominations (cover 

letters and curriculum vitae) should be 

emailed to ACDirector@cdc.gov with the 

subject line: ‘‘Nomination for CDC ACD 

Communications and Public 

Engagement Workgroup.’’ 

FOR FURTHER INFORMATION CONTACT: Kate 

Galatas, MPH, Senior Communications 

Specialist, Office of Communications, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road (MS 

H21–11), Atlanta, GA 30329–4027, 

Telephone: (404) 639–2064; Email: 

ACDirector@cdc.gov. 

SUPPLEMENTARY INFORMATION:

Background: The purpose of the ACD, 

CDC Advisory Committee to the 

Director shall (1) make 

recommendations to the Director 

regarding ways to prioritize the 

activities of the agency in alignment 

with the CDC Strategic Plan required 

under section 305(c); H.R. 2617–1252; 

(2) advise on ways to achieve or 

improve performance metrics in relation 

to the CDC Strategic Plan, and other 

relevant metrics, as appropriate; (3) 

provide advice and recommendations 

on the development of the Strategic 

Plan, and any subsequent updates, as 


khammond on DSKJM1Z7X2PROD with NOTICES